Advertisement
Screener

Unity Biotechnology, Inc. Interest Expense

Unity Biotechnology, Inc. Interest Expense

Unity Biotechnology, Inc. reported Interest Expense of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.

Financial Statements › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2025-03-07

  • Unity Biotechnology, Inc. interest expense for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
  • Unity Biotechnology, Inc. interest expense for the quarter ending 2023-12-31 was $1.00K, a 99.90% decline year-over-year.
  • Unity Biotechnology, Inc. interest expense for the quarter ending 2023-09-30 was $566.00K, a 34.64% decline year-over-year.
  • Unity Biotechnology, Inc. interest expense for the quarter ending 2023-06-30 was $883.00K, a 1.23% decline year-over-year.
  • Unity Biotechnology, Inc. interest expense for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
  • Unity Biotechnology, Inc. interest expense for fiscal 2023 was $2.45M, a 31.08% decline from fiscal 2022.
  • Unity Biotechnology, Inc. interest expense for fiscal 2022 was $3.56M, a 11.99% increase from fiscal 2021.
  • Unity Biotechnology, Inc. interest expense for fiscal 2021 was $3.18M, a 145.90% increase from fiscal 2020.
Period endInterest Expense 3 monthInterest Expense 3 month as first filedInterest Expense 6 monthInterest Expense 6 month as first filedInterest Expense 9 monthInterest Expense 12 month
2024-12-31$0.00
10-K · filed 2025-03-07
2024-03-31$0.00
10-Q · filed 2024-05-14
$1.00K
derived: sum of 2 quarters · filed 2025-03-07
$567.00K
derived: sum of 3 quarters · filed 2025-03-07
$1.45M
derived: sum of 4 quarters · filed 2025-03-07
2023-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07
$567.00K
derived: sum of 2 quarters · filed 2025-03-07
$1.45M
derived: sum of 3 quarters · filed 2025-03-07
$2.45M
10-K · filed 2025-03-07
2023-09-30$566.00K
10-Q · filed 2024-11-04
$470.00K
10-Q · filed 2023-11-13
$1.45M
derived: sum of 2 quarters · filed 2024-11-04
$2.45M
10-Q · filed 2024-11-04
$3.44M
derived: sum of 4 quarters · filed 2025-03-07
2023-06-30$883.00K
10-Q · filed 2024-08-06
$979.00K
10-Q · filed 2023-08-08
$1.89M
10-Q · filed 2024-08-06
$1.98M
10-Q · filed 2023-08-08
$2.88M
derived: sum of 3 quarters · filed 2025-03-07
$3.74M
derived: sum of 4 quarters · filed 2025-03-07
2023-03-31$1.00M
10-Q · filed 2024-05-14
$1.99M
derived: sum of 2 quarters · filed 2025-03-07
$2.86M
derived: sum of 3 quarters · filed 2025-03-07
$3.75M
derived: sum of 4 quarters · filed 2025-03-07
2022-12-31$990.00K
derived: 10-K 12 month − 10-K 9 month · filed 2025-03-07
$1.86M
derived: sum of 2 quarters · filed 2025-03-07
$2.75M
derived: sum of 3 quarters · filed 2025-03-07
$3.56M
10-K · filed 2025-03-07
2022-09-30$866.00K
10-K · filed 2024-04-15
$1.76M
derived: sum of 2 quarters · filed 2024-04-15
$2.57M
10-K · filed 2024-04-15
$3.39M
derived: sum of 4 quarters · filed 2024-04-15
2022-06-30$894.00K
10-Q · filed 2023-08-08
$1.70M
10-Q · filed 2023-08-08
$2.53M
derived: sum of 3 quarters · filed 2024-04-15
$3.32M
derived: sum of 4 quarters · filed 2024-04-15
2022-03-31$808.00K
10-Q · filed 2023-05-09
$1.63M
derived: sum of 2 quarters · filed 2024-04-15
$2.43M
derived: sum of 3 quarters · filed 2024-04-15
$3.21M
derived: sum of 4 quarters · filed 2024-04-15
2021-12-31$826.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15
$1.62M
derived: sum of 2 quarters · filed 2024-04-15
$2.40M
derived: sum of 3 quarters · filed 2024-04-15
$3.18M
10-K · filed 2024-04-15
2021-09-30$792.00K
10-Q · filed 2022-11-08
$1.58M
derived: sum of 2 quarters · filed 2022-11-08
$2.35M
10-Q · filed 2022-11-08
$3.14M
derived: sum of 4 quarters · filed 2023-03-15
2021-06-30$784.00K
10-Q · filed 2022-08-12
$1.56M
10-Q · filed 2022-08-12
$2.35M
derived: sum of 3 quarters · filed 2023-03-15
$2.85M
derived: sum of 4 quarters · filed 2023-03-15
2021-03-31$775.00K
10-Q · filed 2022-05-10
$1.57M
derived: sum of 2 quarters · filed 2023-03-15
$2.07M
derived: sum of 3 quarters · filed 2023-03-15
$2.07M
derived: sum of 4 quarters · filed 2023-03-15
2020-12-31$793.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
$1.29M
derived: sum of 2 quarters · filed 2023-03-15
$1.29M
derived: sum of 3 quarters · filed 2023-03-15
$1.29M
10-K · filed 2023-03-15
2020-09-30$499.00K
10-Q · filed 2021-11-10
$499.00K
derived: sum of 2 quarters · filed 2021-11-10
$499.00K
10-Q · filed 2021-11-10
2020-06-30$0.00
10-Q · filed 2021-08-10
$0.00
10-Q · filed 2021-08-10
2020-03-31$0.00
10-Q · filed 2021-05-11
2019-12-31$0.00
10-K · filed 2022-03-15